Top news of the week: 21.11.2022.
Biosplice, once the most valuable biotech startup, sees a pair of osteoarthritis trials fail
Biosplice announced that its experimental osteoarthritis drug failed to benefit patients in a pair of Phase 3 clinical trials.
Thrive founders launch new blood testing startup to spot when cancer returns
Cancer patients often worry whether the disease will return. A new blood test could offer answers.
Owkin collaborates with Stanford Medicine on lung cancer and mesothelioma treatment research using AI
Owkin, an AI biotech company, is collaborating with Stanford Medicine on research to improve the treatment of lung cancer and mesothelioma. Using Stanford Medicine’s multimodal …
Biotech basket with individual upward outliers
In May, Plattform Life Sciences created its Biotech & Co. basket that included 30 German companies listed in Germany
5 Biopharma Jobs that Don't Require a Ph.D.
If you want to work in biopharma but only have a bachelor’s or master’s degree, there are still plenty of options available. To help, here are five job options in biopharma that don't ...
‘A very worrying scenario’: Internal documents on India Covid-19 vaccine raise troubling questions about approval process
A STAT review of documents on Bharat Biotech's Covid-19 vaccine found that regulators endorsed the vaccine despite discrepancies in the number of enrollees.
FDA Greenlights Provention’s TZIELD as First Drug to Delay Advanced T1D
The FDA has approved Provention’s BLA for intravenous antibody TZIELD to delay stage 3 type 1 diabetes, making it the first disease-modifying drug indicated to slow disease ...
Immutep Limited
I’m very pleased with our clinical data that has grown stronger with time and our team’s operational performance which have brought us to an attractive position where we have the …